Medicine and Dentistry
Adenocarcinoma
14%
Adenoma
13%
Biopsy
17%
Bleeding
21%
Clinical Significance
12%
Colon
12%
Colonoscopy
15%
Colorectal Cancer
21%
Disease
24%
Dysplasia
25%
Endoscopic Mucosal Resection
40%
Endoscopic Submucosal Dissection
100%
Endoscopic Surgery
68%
Endoscopic Ultrasound
17%
Endoscopy
20%
Epstein Barr Virus
12%
Esophageal Cancer
12%
Follow up
12%
Gastroesophageal Reflux
21%
Gastrointestinal Bleeding
14%
Helicobacter Infection
19%
Helicobacter Pylori
25%
Helicobacter Pylori
15%
Hepatocellular Carcinoma
12%
Infection
20%
Inpatient
22%
Ligation
11%
Lymph Node Metastasis
18%
Malignant Neoplasm
12%
Multivariate Analysis
15%
Neoplasm
69%
Odds Ratio
21%
Overall Survival
14%
Peptic Ulcer Bleeding
12%
Predictive Factor
25%
Proton-Pump Inhibitor
17%
Pylorus
39%
Radiofrequency Ablation
18%
Randomized Controlled Trial
16%
Recurrent Disease
17%
Reflux Esophagitis
14%
Retrospective Study
24%
Scoring System
12%
Stomach Cancer
58%
Stomach Cancer
34%
Surgery
62%
Symptom
19%
Therapeutic Procedure
36%
Ulcer
13%
Upper Gastrointestinal Bleeding
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
9%
Adverse Event
16%
Amoxicillin
17%
Amoxicillin
5%
Antibiotic Agent
7%
Antibiotic Resistance
16%
Antibiotics
14%
Bleeding
20%
Chemoradiation Therapy
8%
Chemotherapy
6%
Cisplatin
10%
Clarithromycin
29%
Clarithromycin
5%
Colorectal Cancer
10%
Crohn's Disease
7%
Disease
7%
Disease Activity
6%
Disease Free Survival
5%
Dysplasia
5%
Esomeprazole
8%
Esophagus Cancer
9%
Gastroesophageal Reflux
14%
Gastrointestinal Hemorrhage
11%
Helicobacter Infection
28%
Helicobacter Pylori
46%
Infection
24%
Inflammatory Bowel Disease
14%
Jejunum Ulcer
8%
Lansoprazole
12%
Liver Cell Carcinoma
8%
Metronidazole
16%
Neoplasm
12%
Neoplasm
12%
Non Erosive Reflux Disease
5%
Non-Steroidal Anti-Inflammatory Drug
11%
Omeprazole
9%
Overall Survival
7%
Peptic Ulcer Bleeding
11%
Polyp
6%
Prevalence
5%
Proton Pump Inhibitor
17%
Randomized Clinical Trial
12%
Recurrent Disease
10%
Reflux Esophagitis
12%
Retrospective Study
14%
Stomach Cancer
32%
Survival Rate
6%
Symptom
14%
Ulcer
6%
Upper Gastrointestinal Bleeding
5%